In
addition to leveraging our capabilities for our proprietary product
development programs, we provide services in
genotyping,
structural
biology,
drug discovery and development and clinical development to
pharmaceutical and biotechnology companies.
Through
our subsidiaries deCODE chemistry, based outside Chicago, and deCODE
biostructures, based near Seattle, we provide a full range of
structural biology and drug discovery services. Our CRO subsidiary
Encode offers a complete range of clinical services, including
Information-rich Clinical Trials.
Our services
range from early-stage discovery and optimization to identification of
viable synthetic routes required to manufacture cGMP material in
quantities for pre-clinical and clinical studies. We also
provide genotyping services through our headquarters facility in
Iceland, the most advanced and highest-throughput microsatellite
genotyping laboratory in the world. Our customers for
genotyping services include pharmaceutical companies, research
consortia and academic institutions.
Genotyping
deCODE's
genotyping service delivers rapid-turnaround, high-quality data for
linkage analyses. deCODE can process whole blood, buffy coat, and DNA
samples, perform genome-wide scans and deliver quality-controlled
genotypes within weeks. Backed by years of experience we have created
the most complete genetic map of the human genome and an unrivalled
track record in mapping and validating disease genes for common
diseases.
Structural biology
deCODE
biostructures is a leading provider of contract research services in
X-ray crystallographic structure determination of protein-ligand
complexes. deCODE biostructures' capabilities span the entire
gene-to-structure landscape including whole-gene synthesis,
gene-construct engineering, large scale protein production and
purification, high-throughput crystallization screening, small molecule
pre-formulation screening, X-ray diffraction data collection, model
building, and refinement.
More information
is available on the
deCODE chemistry & biostructures website,
www.decodechembio.com
Chemistry
deCODE
chemistry takes a unique and comprehensive approach to drug discovery
partnerships. deCODE's chemistry group, located in Woodridge, IL,
offers a full range of drug discovery solutions for selecting
high-quality drug candidates quickly and advancing drug development
programs into the clinic. As part of deCODE's integrated lead
optimization approach, deCODE chemistry identifies candidate compounds
that are potent against and specific for virtually any target, as well
as optimized for pharmaceutical properties.
More
information is available on the
deCODE chemistry & biostructures website,
www.decodechembio.com
Clinical development
Through
our fully owned CRO subsidiary Encode we offer a complete range of
clinical trials services Phase I-IV, pharmacokinetics/bioequivalence
studies and analytical services. We can also combine population
genetics and clinical trials resources in Information-rich Clinical
Trials
TM, where detailed data on a number of
genetic and phenotypic variables enables us to determine not just
whether people respond to drugs, but also who responds best and why.
